Head-to-head · Cost-Efficiency Index
Rivo Health vs Goldspan Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Rivo Health
Patients willing to commit to a 12-month prepay plan to reach the advertised $149-199/mo rate, who also want dietitian and coaching support bundled in.
Visit Rivo HealthGoldspan Health
Shoppers who want a sublingual route priced openly beside the injection and who will count 13 charges a year rather than 12.
Visit Goldspan HealthThe verdict
Rivo Health and Goldspan Health tie on the Cost-Efficiency Index at 71/100, so neither wins outright on the numbers. For most shoppers we'd start with Rivo Health (ranked #76, a hair above #77) — Patients willing to commit to a 12-month prepay plan to reach the advertised $149-199/mo rate, who also want dietitian and coaching support bundled in. But Goldspan Health is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Rivo Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Rivo Health | Goldspan Health |
|---|---|---|
| Cost-Efficiency Index | 71/100 | 71/100 |
| Semaglutide / mo | $149/mo (starting dose, annual plan, compounded oral) | $229 every 28 days month-to-month (13 charges a year, not 12) |
| Tirzepatide / mo | $199/mo (starting dose, annual plan, compounded oral) | $299 every 28 days month-to-month (13 charges a year, not 12) |
| Semaglutide / yr (modeled) | $1,788 | $2,748 |
| Tirzepatide / yr (modeled) | $2,388 | $3,588 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #76 | #77 |
Rivo Health
71/100Where the value is
- Bundles a membership (unlimited provider visits, dietitian, coaching) into the plan at no separately-billed cost
- Large, established program with a stated 115,000+ member base and 4.7 Trustpilot rating
- Both injectable and oral compounded options for semaglutide and tirzepatide
The tradeoffs
- The headline $149/$199 prices require a 12-month annual-plan commitment — the genuine month-to-month rate, shown crossed out on the same page, is $279/mo and $389/mo, 87-95% higher
- Compounding pharmacy partner is not named anywhere reachable
Goldspan Health
71/100Where the value is
- Prices ten separate GLP-1 products openly — injection and sublingual, standard and low dose, with a B12 or a glycine base — before any account
- Each plan card itemizes what the figure buys: the clinician evaluation, the medication, injection supplies, two-day shipping and clinical-team access
- States the billing cycle honestly on the plan card and the order timeline as 28 days and four weeks
The tradeoffs
- The hero prints "/month" over a plan billed every 28 days, which is 13 charges a year rather than 12
- "Pause, delay, or cancel at any time" sits against a refund policy reading "all sales are final" and storefront terms saying an order cannot be canceled once placed
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.